Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sternberg

Showing results (261-270 of 564) with videos related to

Pageof 57
Sort By:
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.
The Lancet. Oncology|June 12, 2010
Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urotheliumGuru Sonpavde, Cora N Sternberg, Jonathan E Rosenberg, et al.
The Journal of Urology|December 1, 1995
Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term resultsV Pansadoro, P Emiliozzi, L Defidio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancerM G Arena, C N Sternberg, M Zeuli, et al.
Oncology|February 23, 2016
Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover--The Case of Pazopanib in Advanced Renal Cell CarcinomaJose Diaz, Cora N Sternberg, Faisal Mehmud, et al.
Critical Reviews in Oncology/Hematology|February 14, 2002
Bladder cancerFilippo de Braud, Massimo Maffezzini, Vito Vitale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
European Urology|June 21, 2011
Sequelae of treatment in long-term survivors of testis cancerRobert Abouassaly, Sophie D Fossa, Aleksander Giwercman, et al.
European Urology|August 30, 2011
Contemporary role of androgen deprivation therapy for prostate cancerVincenzo Pagliarulo, Sergio Bracarda, Mario A Eisenberger, et al.
British Journal of Cancer|November 7, 2014
Comparing comparators: a look at control arms in kidney cancer studies over the yearsS Bracarda, C Porta, M Sisani, et al.
Pageof 57

Showing results (261-270 of 564) with videos related to

Sort By:
Pageof 57
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.
The Lancet. Oncology|June 12, 2010
Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urotheliumGuru Sonpavde, Cora N Sternberg, Jonathan E Rosenberg, et al.
The Journal of Urology|December 1, 1995
Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term resultsV Pansadoro, P Emiliozzi, L Defidio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancerM G Arena, C N Sternberg, M Zeuli, et al.
Oncology|February 23, 2016
Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover--The Case of Pazopanib in Advanced Renal Cell CarcinomaJose Diaz, Cora N Sternberg, Faisal Mehmud, et al.
Critical Reviews in Oncology/Hematology|February 14, 2002
Bladder cancerFilippo de Braud, Massimo Maffezzini, Vito Vitale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
European Urology|June 21, 2011
Sequelae of treatment in long-term survivors of testis cancerRobert Abouassaly, Sophie D Fossa, Aleksander Giwercman, et al.
European Urology|August 30, 2011
Contemporary role of androgen deprivation therapy for prostate cancerVincenzo Pagliarulo, Sergio Bracarda, Mario A Eisenberger, et al.
British Journal of Cancer|November 7, 2014
Comparing comparators: a look at control arms in kidney cancer studies over the yearsS Bracarda, C Porta, M Sisani, et al.
Pageof 57